NNP
ASXC

Nachman Norwood & Parrott’s Asensus Surgical, Inc. ASXC Stock Holding History

Nachman Norwood & Parrott’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-915
Closed -$16K – 242
2019
Q2 		$16K Buy
+915
New +$20K ﹤0.01% 238

Other funds holding ASXC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LM
Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return

Nachman Norwood & Parrott's ASXC Position: Q3 2019 in Review

Nachman Norwood & Parrott sold out of Asensus Surgical, Inc. (ASXC) in Q3 2019, closing a stake of 915 shares — an estimated $16K sold.

Nachman Norwood & Parrott first reported a position in ASXC in Q2 2019 and held it in 1 quarter. The position peaked at $16K in Q2 2019. 130 funds tracked by Wall St. Rank hold ASXC as of Q3 2019.

  • Nachman Norwood & Parrott reported no remaining Asensus Surgical, Inc. position as of Q3 2019 after selling out during the quarter.
  • Nachman Norwood & Parrott sold 915 Asensus Surgical, Inc. shares in Q3 2019, an estimated $16K.
  • Nachman Norwood & Parrott first reported a position in Asensus Surgical, Inc. in Q2 2019 and held it in 1 quarter.
  • Nachman Norwood & Parrott's Asensus Surgical, Inc. position peaked at $16K in Q2 2019.
  • 130 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2019.

Based on Nachman Norwood & Parrott's 13F filing for Q3 2019, filed 9 Oct 2019.